Gevork Minaskanian
American academic
Gevork Minaskanian's AcademicInfluence.com Rankings

Download Badge
Computer Science
Gevork Minaskanian's Degrees
- Masters Computer Science Stanford University
- Bachelors Computer Science University of California, Berkeley
Similar Degrees You Can Earn
Why Is Gevork Minaskanian Influential?
(Suggest an Edit or Addition)According to Wikipedia, Gevork Minaskanian is an American research professor in the Department of Chemistry at Virginia Commonwealth University and Co-founder/Vice President of Synthetic Chemistry at Aderis Pharmaceuticals who was a contributor to the development of rotigotine and Neupro . Rotigotine is a drug developed to mimic the actions of dopamine in the brain to help cope with restless legs syndrome and the abnormal movements found in Parkinson's disease patients. This drug is an alternative to oral medications for treatment of Parkinson's disease, considered by the VCU Department of Chemistry as "an unprecedented medication for the benefit of millions of Parkinson's patient worldwide." Minaskanian’s main contribution to Neupro was improving the efficiency of manufacturing rotigotine, thereby making the process commercially viable and enabling patients to afford this important medication. Dr. Minaskanian is the inventor and author of over 50 patents and publications in various fields of organic and medicinal chemistry. Some of his US patents include patents 5,470,848; 4,801,586; 5,234,959; 5,118,676; and other related research done on rotigotine and Neupro US patent 7,309,497 found in the United States Patent and Trademark Office linked to the penetration enhancers for transdermal delivery of systemic agents.
Gevork Minaskanian's Published Works
Published Works
- EFFICIENT REGIOCONTROLLED SYNTHESIS OF SARKOMYCIN AND HOMOSARKOMYCIN (1982) (27)
- Regiospecific synthesis of sarkomycin and some analogs (1982) (23)
- Preparation, stereochemistry, and nuclear magnetic resonance spectroscopy of 4-hydroxy(acetoxy)bicyclo[5.1.0]octanes. Synthesis of (-)- and (.+-.)-8,8-dimethylbicyclo[5.1.0]oct-2-en-4-one (1982) (21)
- 2-Carbomethoxycyclopentenone as a synthon. synthesis of sarkomycin☆ (1979) (15)
- An antibody to dihydropyridine calcium entry blockers. A comparison with the calcium channel receptor in skeletal muscle. (1986) (8)
- PREPARATION, STEREOCHEMISTRY, AND NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY OF 4-HYDROXY(ACETOXY)BICYCLO(5.1.0)OCTANES. SYNTHESIS OF (-)- AND (.+-.)-8,8-DIMETHYLBICYCLO(5.1.0)OCT-2-EN-4-ONE (1983) (1)
- Skin penetration enhancing compositions. (1987) (0)
- A method of preparing a composition for enhancing the membrane penetration of at least one systemically active agent. (1987) (0)
- Penetration enhancers for the transdermal administration of systemically active pharmaceuticals. (1987) (0)
- METHOXYCARBONYLCYCLOPENTENONE AS A SYNTHON. SYNTHESIS OF SARKOMYCIN (1980) (0)
- Synthesis of an anti-cancer compound, sarkomycin, and some analogs (1979) (0)
- United States Patent ( 19 ) Minaskanian et al . ( 54 ) N-SUBSTITUTED THIOLACTAMS 75 ) Inventors : (2017) (0)
- Preparations of 1-acyl substituted morpholines, -thiomorpholines and piperazines. (1987) (0)
- An improved process for preparing N-substituted aminotetralins (2000) (0)
- Eindringungserhöhende medium for transdermal administration of systemic agents. (1987) (0)
- 2-aminotetralins substituted. (1994) (0)
This paper list is powered by the following services:
Other Resources About Gevork Minaskanian
What Schools Are Affiliated With Gevork Minaskanian?
Gevork Minaskanian is affiliated with the following schools: